2022
DOI: 10.4049/immunohorizons.2000072
|View full text |Cite
|
Sign up to set email alerts
|

IL-17 Receptor Signaling through IL-17A or IL-17F Is Sufficient to Maintain Innate Response and Control of Helicobacter pylori Immunopathogenesis

Abstract: IL-17R signaling is required for control of extracellular pathogens and is also implicated in development of chronic inflammatory processes. The response to the human pathogen Helicobacter pylori results in Th1 and Th17 cell activation and a chronic inflammatory process that can lead to adverse outcomes, such as gastric cancer. Previously, we identified IL-17RA as a requirement for the recruitment of neutrophils and control of H. pylori colonization in the gastric mucosa. Unexpectedly, H. pylori-infected Il17r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 54 publications
0
3
0
Order By: Relevance
“…Recently, the IL-17 proinflammatory cytokine has gained attention among malaria researchers because of its protective role in immunity against extracellular pathogens [ 6 8 ] and for the clearance of intracellular pathogens [ 9 11 ]. In addition to its essential role in protective immunity, IL-17 is critical in the pathogenesis of various autoimmune inflammatory diseases.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, the IL-17 proinflammatory cytokine has gained attention among malaria researchers because of its protective role in immunity against extracellular pathogens [ 6 8 ] and for the clearance of intracellular pathogens [ 9 11 ]. In addition to its essential role in protective immunity, IL-17 is critical in the pathogenesis of various autoimmune inflammatory diseases.…”
Section: Introductionmentioning
confidence: 99%
“…Consequently, in oncology, IL-6/STAT3 is the target of several therapies. IL-6 and STAT3 inhibition may represent a likely target that could revert acquired resistance [ 39 ]. In this context, increased IL-6 secretion, together with the upregulation of GP130, the IL-6 receptor, is likely responsible for increased STAT3 expression and poor sensitivity to treatment with chemotherapeutic agents.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, the IL-17 proin ammatory cytokine has gained attention among malaria researchers because of its protective role in immunity against extracellular pathogens [5][6][7] and for the clearance of intracellular pathogens [8][9][10]. In addition to its essential role in protective immunity, IL-17 is critical in the pathogenesis of various autoimmune in ammatory diseases.…”
Section: Introductionmentioning
confidence: 99%